In drug development, intelligent investment in time and money and quality up front saves time and money and ensures quality at the end
(PRWEB) June 13, 2014
Intelligent Drug Development, a new book by Dr. Michael Tansey, has just been published by Oxford University Press (ISBN 978-0-19-997458-0).
To bring a drug from the laboratory bench to the patient’s bedside is a difficult and challenging process. Often the complexity is unnecessarily intensified by poor planning and manmade mistakes. This new book for the first time systematically describes what can be done to improve planning, and how to pragmatically avoid/minimize mistakes. Simply put, intelligent investment in time and money and quality up front saves time and money and ensures quality at the end.
Dr. Tansey is one of the few thinkers in our industry willing to take the steps beyond “quick fixes” in dealing with repeated crises in clinical trial execution. His new book is undoubtedly a valuable addition to our industry’s forlorn library.
Dr. Tansey is the former Chief Medical Officer of Pharmacia, and a strategic partner of PhESi. PhESi (http://www.PhESi.com) is a data-driven consulting firm servicing drug development organizations around the world, including site selection and clinical trial feasibility analysis.